Caribou Biosciences, Inc.
CRBU
$1.44
-$0.10-6.49%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -103.40M | -133.22M | -148.13M | -157.13M | -164.26M |
| Total Depreciation and Amortization | 2.59M | 3.13M | 3.65M | 4.15M | 4.69M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 11.41M | 32.78M | 33.97M | 34.00M | 34.52M |
| Change in Net Operating Assets | -6.38M | -3.94M | -484.00K | -6.65M | -8.07M |
| Cash from Operations | -95.78M | -101.25M | -110.99M | -125.64M | -133.11M |
| Capital Expenditure | 28.00K | -389.00K | -1.36M | -2.09M | -2.65M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | 13.00K | 13.00K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 71.72M | 77.23M | 103.60M | 102.28M | 118.51M |
| Cash from Investing | 71.75M | 76.84M | 102.24M | 100.20M | 115.87M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 24.98M | 7.05M | 4.82M | 4.61M | 4.58M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 24.98M | 7.05M | 4.82M | 4.61M | 4.58M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 947.00K | -17.36M | -3.93M | -20.83M | -12.67M |